Waratah Capital Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-40,294
Closed -$2.12M – 193
2022
Q2
$2.12M Buy
40,294
+14,341
+55% +$998K 0.05% 114
2022
Q1
$2.23M Buy
+25,953
New +$2.13M 0.03% 129

Other funds holding THC

Waratah Capital Advisors's THC Position: Q3 2022 in Review

Waratah Capital Advisors sold out of Tenet Healthcare (THC) in Q3 2022, closing a stake of 40,294 shares — an estimated $2.12M sold.

Waratah Capital Advisors first reported a position in THC in Q1 2022 and held it in 2 quarters. The position peaked at $2.23M in Q1 2022. 360 funds tracked by Wall St. Rank hold THC as of Q3 2022.

  • Waratah Capital Advisors reported no remaining Tenet Healthcare position as of Q3 2022 after selling out during the quarter.
  • Waratah Capital Advisors sold 40,294 Tenet Healthcare shares in Q3 2022, an estimated $2.12M.
  • Waratah Capital Advisors first reported a position in Tenet Healthcare in Q1 2022 and held it in 2 quarters.
  • Waratah Capital Advisors's Tenet Healthcare position peaked at $2.23M in Q1 2022.
  • 360 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2022.

Based on Waratah Capital Advisors's 13F filing for Q3 2022, filed 7 Nov 2022.